Common back-pain drug may be linked to higher dementia risk, large study finds

A Growing Body of Concern
This latest study is part of a broader and evolving conversation about gabapentin’s side effect profile. Earlier research has already raised concerns about the medication’s potential effects on breathing, particularly in individuals with respiratory conditions or when combined with other substances that affect the central nervous system. Other commonly reported side effects include dizziness, unusual fatigue, swelling, and dry mouth.

These concerns do not mean the medication is dangerous for everyone, but they do suggest that — like all medications — gabapentin comes with a risk-benefit calculation that deserves ongoing scrutiny.

The Bottom Line
Gabapentin has provided meaningful relief for millions of people living with chronic pain, and that should not be minimized. For many patients, it remains a valuable tool in managing conditions that can significantly diminish quality of life.

But the findings from this large-scale study add an important layer of complexity to the conversation. The potential link between long-term gabapentin use and cognitive decline — particularly among adults in their 30s, 40s, and 50s — is a development that both patients and healthcare providers deserve to be informed about.

As the researchers put it, their results support the need for careful, ongoing monitoring of patients on gabapentin therapy. In a country where the drug is prescribed to tens of millions of people each year, that message carries real weight.

If you are currently taking gabapentin, the best step you can take is to stay informed and maintain an open, ongoing dialogue with your doctor about your long-term treatment options.